Skip Nav Destination
1-3 of 3
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell Lymphoma
Reid W Merryman, MD, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Kristin M McHugh, Jennifer R. Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric Jacobsen, MD, Caron Jacobson, MD MMSc, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Ng, MD PhD, Oreofe O. Odejide, MDMPH, Parastoo B. Dahi, MD, Yago Nieto, MD, Robin M. Joyce, MD, Yi-Bin Chen, MD, Alex F. Herrera, MD, Philippe Armand, MD PhD
Blood (2020) 136 (Supplement 1): 22–23.
Updated Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab (AVO) for Frontline Treatment of Chronic Lymphocytic Leukemia (CLL)
Matthew S. Davids, MD, Benjamin L. Lampson, MD PhD, Svitlana Tyekucheva, PhD, Jennifer L. Crombie, MD, Samuel Ng, MD PhD, Austin I. Kim, MD, Matthew Weinstock, MD, Jessica Lowney, Samantha Pazienza, Josie Montegaard, NP, Victoria Patterson, BSN, RN, Caron A. Jacobson, MD, Ann S. LaCasce, MD MSc, Philippe Armand, MD PhD, Jon E. Arnason, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Blood (2020) 136 (Supplement 1): 20–21.
Characterizing the Anti-Apoptotic Dependencies of T-Cell Prolymphocytic Leukemia Identifies HDAC and JAK/STAT Pathway Inhibitors As Promising Combination Partners to Augment Bcl-2 Targeted Killing By Venetoclax
Charles Herbaux, MD MSc, Christoph Kornauth, Stéphanie Poulain, MD PhD, Olivier Tournilhac, Mary C Collins, BA, Rebecca Valentin, MD, Stephen Jun Fei Chong, PhD, Jehan Dupuis, MD, Adrien Daniel, Micha Srour, MD, Cecile Tomowiak, MD, Kamel Laribi, MD, Damien Roos-Weil, Cedric Rossi, MD PhD, Nicolas Vanlangendonck, MSc, Cecile Leyronnas, Fatiha Merabet, MD, Jean Valère Malfuson, MD, Mourad Tiab, Samuel Ng, MD PhD, Franck Morschhauser, MD, Philipp Bernhard Staber, MD PhD, Matthew S. Davids, MD
Blood (2019) 134 (Supplement_1): 807.